Nátrium-Citrát Grifols (Sodium Citrate)

Sodium citrate, the active ingredient in Nátrium-Citrát Grifols, is an Anticoagulant presented as a sterile solution for intravenous use. It chelates calcium ions, thereby inhibiting clot formation in blood products and during extracorporeal procedures. GNH USA supplies Nátrium-Citrát Grifols as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Sodium citrate acts as an anticoagulant and alkalinising agent across several clinical pathways. - Blood collection: maintains fluidity of drawn blood for laboratory analysis. - Hemodialysis: prevents clotting in the extracorporeal circuit during treatment. - Cardiopulmonary bypass: provides anticoagulation while the heart‑lung machine is in use. - Urinary alkalinisation: raises urine pH to facilitate excretion of certain drugs or toxins.

Sodium citrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Mild metabolic alkalosis: slight elevation of blood pH. - Hypernatremia: increased serum sodium levels. - Nausea or vomiting: gastrointestinal discomfort. - Headache: transient cranial pain. - Local infusion site irritation: redness or mild pain at the catheter site.

Serious or Rare Side Effects: - Severe hypernatremia: can lead to neurological symptoms. - Severe metabolic alkalosis: may cause respiratory depression. - Anaphylactic reaction: rare but potentially life‑threatening. - Cardiac arrhythmia: due to electrolyte shifts. - Hypotension: sudden drop in blood pressure. - Renal dysfunction: impaired kidney function in susceptible patients.

When using sodium citrate, clinicians should observe several safety measures. - Renal impairment: monitor serum electrolytes and fluid balance. - Cardiac disease: watch for arrhythmias and blood pressure changes. - Pregnancy: use only if clearly indicated, weighing maternal benefit against fetal risk. - Elderly patients: consider reduced renal clearance and adjust monitoring. - Concomitant calcium‑containing medications: avoid additive calcium load that may diminish anticoagulant effect. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium citrate can interact with several drug classes; awareness helps prevent complications.

Major Interactions (Avoid): - Calcium‑containing IV solutions: may neutralise citrate’s anticoagulant action. - Alkali‑producing agents (e.g., acetazolamide): can exacerbate metabolic alkalosis. - Loop diuretics: increase risk of electrolyte imbalance, especially hypocalcaemia.

Moderate Interactions (Monitor Closely): - Warfarin or other oral anticoagulants: heightened bleeding risk when combined. - ACE inhibitors or ARBs: monitor blood pressure for additive hypotensive effect. - Beta‑blockers: observe for excessive bradycardia or hypotension. - Other anticoagulants (e.g., heparin): assess coagulation parameters closely.